1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 用途別スニペット
3.3. エンドユーザー別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 非侵襲的診断手順の需要の増加
4.1.2. 阻害要因
4.1.2.1. 超音波シミュレーションソフトウェアとハードウェアの高コスト
4.1.2.2. CTスキャンやMRIなどの代替画像技術
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. アンメット・ニーズ
5.6. PESTEL分析
5.7. 特許分析
5.8. SWOT分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数（製品タイプ別
6.2. サービス＆ソフトウェア
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. デバイス
7. 用途別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析（%）, アプリケーション別
7.1.2. 市場魅力度指数：用途別
7.2. 放射線*分野
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 循環器
7.4. 婦人科
7.5. その他
8. エンドユーザー別
8.1. 導入
8.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
8.1.2. 市場魅力度指数、エンドユーザー別
8.2. 病院・手術センター*市場
8.2.1. はじめに
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. 診断センター
8.4. その他
9. 地域別
9.1. 導入
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.2.4. 市場規模分析とYoY成長率分析（%）, アプリケーション別
9.2.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.2.6. 市場規模分析および前年比成長率分析(%)、国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.3.4. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.3.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.3.6. 市場規模分析および前年比成長率分析(%)、国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. イタリア
9.3.6.5. スペイン
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.4.4. 市場規模分析および前年比成長率分析 (%)、用途別
9.4.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.4.6. 市場規模分析および前年比成長率分析(%)、国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.5.4. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.5.5. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
9.5.6. 市場規模分析および前年比成長率分析(%)、国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. 韓国
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 製品タイプ別
9.6.4. 市場規模分析および前年比成長率分析（%）, アプリケーション別
9.6.5. 市場規模分析および前年比成長率分析（%）, エンドユーザー別
10. 競合情勢
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Surgical Science Sweden AB *
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. GE Healthcare
11.3. Laerdal Medical
11.4. Echocom GmbH
11.5. Intelligent Ultrasound.
11.6. Virtamed
11.7. CAE Healthcare
11.8. Simulab Corporation
11.9. Gaumard Scientific
11.10. Shimadzu Corporation(リストは完全ではありません）
12. 付録
12.1. 島津製作所について
12.2. お問い合わせ
The global ultrasound simulation market reached US$ 143.45 million in 2023 and is expected to reach US$ 382.31 million by 2031, growing at a CAGR of 13.4% during the forecast period 2024-2031.
An Ultrasound Simulator is a medical simulation training tool that enables educators and learners to practice diagnostic, therapeutic, and surgical applications as they relate to imaging interventions. Ultrasound simulation has the advantage that the practice makes advanced visualization, case databases and automatically generated feedback possible. During fully immersive medical simulation learners enter into a realistic healthcare setting where a high-fidelity patient manikin is being wirelessly operated by both educational and simulation technical staff.
Ultrasound simulation has been proven to reduce medical errors and the associated costs all while improving outcomes in patient care. Technological advancements have primarily driven the global ultrasound simulation market in recent years and are expected to remain the same over the forecast period. Technological advancements are creating realistic learning environments and increasing patient safety.
Market Dynamics: Drivers
Increasing demand for non-invasive diagnostic procedures
The rising demand for non-invasive diagnostic procedures propels the market growth. Ultrasound imaging is a non-invasive and safe diagnostic method that does not involve radiation exposure, making it an attractive option for patients and healthcare providers. As the demand for non-invasive diagnostic procedures continues to grow, the demand for ultrasound simulation technologies is also increasing. As the demand for non-invasive diagnostic procedures continues to grow, the demand for ultrasound simulation technologies is also increasing. Simulation technologies can help to optimize ultrasound imaging parameters such as frequency and beam shape, leading to more accurate and reliable imaging results.
This can improve the efficiency and effectiveness of ultrasound imaging, leading to better patient outcomes and more efficient use of healthcare resources. Ultrasound simulation can also be used to train medical professionals on the principles of ultrasound imaging, allowing them to develop their skills in a safe and controlled environment. This can help to improve the quality and consistency of ultrasound imaging across different healthcare settings. Overall, the increasing demand for non-invasive diagnostic procedures is a key driver for the ultrasound simulation market, as it creates a need for technologies that can improve the accuracy and efficiency of ultrasound imaging.
Restraints
Factors such as the high cost of ultrasound simulation software and hardware and alternative imaging technologies such as CT scan technology and MRI technology are expected to hamper the market. The higher prices of ultrasound simulation software and hardware are affecting the affordability of end users and it acts as a restraint to the market.
Segment Analysis
The global ultrasound simulation market is segmented based on product type, application, end-user, and region.
The segment services and software accounted for approximately 42.6% of the global ultrasound simulation market share
The services and software segment is expected to hold the largest market share over the forecast period. In this segment, technological advancements would drive this market.
Ultrasound simulation software is a medical training tool that helps people learn and practice ultrasound imaging techniques. Ultrasound simulators can help beginners learn how to perform specific ultrasound techniques, such as transthoracic or transesophageal echocardiography (TTE, TEE). Ultrasound simulators can help researchers develop new algorithms and protocols, and improve research lab efficiency.
For instance, in May 2024, 3B Scientific launched e Sono, a cloud-based software-as-a-service (SaaS) ultrasound simulator that allows learners and clinicians of all levels of experience to practice and simulate real ultrasound scenarios. The simulator features a library of real ultrasound clinical cases, including pathology and nonpathology cases sourced from patients. The simulator is designed to meet the needs of both educators and learners. e Sono also features custom content creation to address specific curricular requirements, automated performance feedback to track progress, and the ability to accommodate an unlimited number of users.
Geographical Analysis
North America accounted for approximately 48.3% of the global ultrasound simulation market share
North America region is expected to hold the largest market share over the forecast period. The technological advancements, in this region, help to propel the market.
For instance, in August 2024, medical imaging technology firm Rezolut launched its SecondReadAI mammography reading technology, which uses AI algorithms developed by Lunit. SecondReadAI provides an additional analysis to detect details on mammograms that could be overlooked by interpreting physicians, serving as a second opinion in mammography reading. The company touted research showing that the technology increases early-stage cancer detection by as much as 15%.
Moreover, in July 2024, Simulab Corporation announced the launch of its latest innovation the ultrasound-guided intravenous access arm. This new Ultrasound-Guided Intravenous Access Arm is an anatomically correct, easy-to-use, and affordable task trainer designed to enhance training in IV Access, Peripheral Intravenous Cannulation, and Peripheral Line Placement. The trainer features an extended right arm with both palpable and ultrasound-compatible anatomy, ensuring a comprehensive and realistic training experience.
Market Segmentation
By Product Type
Services & Software
Devices
By Application
Radiology
Cardiology
Gynecology
Others
By End-User
Hospitals & Surgical Center
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Middle East and Africa
Competitive Landscape
The major global players in the global ultrasound simulation market include Surgical Science Sweden AB, GE Healthcare, Laerdal Medical, Echocom GmbH, Intelligent Ultrasound, Virtamed, CAE Healthcare, Simulab Corporation, Gaumard Scientific, and Shimadzu Corporation among others.
Key Developments
In April 2024, Cardiff-based Intelligent Ultrasound Group announced the launch of new software. The 'classroom to clinic' ultrasound company, which specializes in AI software and simulation, revealed that GE Healthcare's SonoLyst software, powered by Intelligent Ultrasound's ScanNav AI, has been launched. It has been launched on the new Voluson Signature Series portfolio of ultrasound machines, the Signature 20 and Signature 18. SonoLystlive enhances ultrasound image recognition by automatically capturing images in real-time, as the clinician scans a mid-trimester patient.
Why Purchase the Report?
To visualize the global ultrasound simulation
Market Segmentation based on product type, application, infection, end-user, and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development
Excel data sheet with numerous data points of global ultrasound simulation market level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.
The global ultrasound simulation market report would provide approximately 51 tables, 54 figures, and 181 Pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Demand for Non-Invasive Diagnostic Procedures
4.1.2. Restraints
4.1.2.1. High Cost Of Ultrasound Simulation Software And Hardware
4.1.2.2. Alternative Imaging Technologies Such as CT scans and MRI
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PESTEL Analysis
5.7. Patent Analysis
5.8. SWOT Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Services & Software *
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Devices
7. By Application
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Radiology *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Cardiology
7.4. Gynecology
7.5. Others
8. By End-User
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals & Surgical Center*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Diagnostic Centers
8.4. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. U.S.
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. South Korea
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Surgical Science Sweden AB *
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. GE Healthcare
11.3. Laerdal Medical
11.4. Echocom GmbH
11.5. Intelligent Ultrasound.
11.6. Virtamed
11.7. CAE Healthcare
11.8. Simulab Corporation
11.9. Gaumard Scientific
11.10. Shimadzu Corporation (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
*** 超音波シミュレーションの世界市場に関するよくある質問(FAQ) ***
・超音波シミュレーションの世界市場規模は？
→DataM Intelligence社は2023年の超音波シミュレーションの世界市場規模を1億4345万米ドルと推定しています。
・超音波シミュレーションの世界市場予測は？
→DataM Intelligence社は2031年の超音波シミュレーションの世界市場規模を3億8231万米ドルと予測しています。
・超音波シミュレーション市場の成長率は？
→DataM Intelligence社は超音波シミュレーションの世界市場が2024年～2031年に年平均13.4%成長すると展望しています。
・世界の超音波シミュレーション市場における主要プレイヤーは？
→「Surgical Science Sweden AB、GE Healthcare、Laerdal Medical、Echocom GmbH、Intelligent Ultrasound、Virtamed、CAE Healthcare、Simulab Corporation、Gaumard Scientific、島津製作所など ...」を超音波シミュレーション市場のグローバル主要プレイヤーとして判断しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、最終レポートの情報と少し異なる場合があります。
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
